Artificial Organ Market is estimated to witness surging demand at a CAGR of 5.15% by 2029
Data Bridge Market Research analyses that the Artificial Organ Market is growing at a CAGR of 9.10% during the forecast period and is likely to reach USD 43.64 billion in 2029. Industry Analysis More than 650,000 patients, per year, in the United States and an estimated 2 million patients worldwide are affected by end-stage renal disease (ESRD). Those who live with end-stage renal disease (ESRD) make only 1% of the medicare-covered population, but account for 7% of the medicare budget. The number of patients in the United States diagnosed with end-stage renal disease (ESRD) is increasing by 5% each year. Mortality rates vary depending on the end-stage renal disease (ESRD) treatment. After one year of treatment, those on dialysis have a 20-25% mortality rate, with a five-year survival rate of 35%. People who receive transplants have a 3% mortality rate after five years. An artificial organ is a medical device that is implanted or integrated into the body to replicate or...